Nan Fung Group Holdings’s Ascendis Pharma A/S ASND Stock Holding History

Nan Fung Group Holdings’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.63M	Hold	13,600	–	–	2.76%	9
2026 Q1	$3.11M	Hold	13,600	–	–	2.57%	9
2025 Q4	$2.9M	Hold	13,600	–	–	2.6%	11
2025 Q3	$2.7M	Hold	13,600	–	–	4.54%	9
2025 Q2	$2.35M	Hold	13,600	–	–	3.7%	9
2025 Q1	$2.12M	Hold	13,600	–	–	1.73%	20
2024 Q4	$1.87M	Hold	13,600	–	–	1.6%	21
2024 Q3	$2.03M	Hold	13,600	–	–	1.75%	20
2024 Q2	$1.85M	Hold	13,600	–	–	1.98%	17
2024 Q1	$2.06M	Buy	+13,600	New	+$1.94M	1.91%	16
2023 Q2	–	Sell	-4,168	Closed	-$447K	–	44
2023 Q1	$447K	Hold	4,168	–	–	0.3%	34
2022 Q4	$509K	Hold	4,168	–	–	0.35%	28
2022 Q3	$430K	Hold	4,168	–	–	0.27%	27
2022 Q2	$387K	Hold	4,168	–	–	0.27%	29
2022 Q1	$489K	Sell	4,168 -8,432	-67%	-$977K	0.23%	31
2021 Q4	$1.7M	Buy	+12,600	New	+$1.87M	0.5%	21

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Nan Fung Group Holdings's ASND Position: Q2 2026 in Review

Nan Fung Group Holdings held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 13,600 shares worth $3.63M. The position accounts for 2.76% of the portfolio, ranked #9.

Nan Fung Group Holdings first reported a position in ASND in Q4 2021 and has held it in 16 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Nan Fung Group Holdings held 13,600 shares of Ascendis Pharma A/S worth $3.63M as of Q2 2026.
Nan Fung Group Holdings left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up 2.76% of Nan Fung Group Holdings's portfolio in Q2 2026, its #9 holding.
Nan Fung Group Holdings first reported a position in Ascendis Pharma A/S in Q4 2021 and has held it in 16 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.